206 related articles for article (PubMed ID: 1561674)
1. Antiphospholipid cofactor.
Gharavi AE
Stroke; 1992 Feb; 23(2 Suppl):I7-10. PubMed ID: 1561674
[TBL] [Abstract][Full Text] [Related]
2. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of human immunodeficiency virus and chlorpromazine induced antiphospholipid antibodies: effect of beta 2 glycoprotein I on binding to phospholipid.
Gharavi AE; Sammaritano LR; Wen J; Miyawaki N; Morse JH; Zarrabi MH; Lockshin MD
J Rheumatol; 1994 Jan; 21(1):94-9. PubMed ID: 8151598
[TBL] [Abstract][Full Text] [Related]
4. Anti beta 2-glycoprotein I antibodies in a patient with catastrophic antiphospholipid syndrome.
Pengo V; Biasiolo A; Grazia Fior M; Ruffatti A
Clin Rheumatol; 1995 Nov; 14(6):646-9. PubMed ID: 8608682
[TBL] [Abstract][Full Text] [Related]
5. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR
J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
[TBL] [Abstract][Full Text] [Related]
6. Phospholipid specificity and requirement of beta 2-glycoprotein-I for reactivity of antibodies from patients with primary antiphospholipid syndrome.
Cabral AR; Cabiedes J; Alarcón-Segovia D; Sánchez-Guerrero J
J Autoimmun; 1992 Dec; 5(6):787-801. PubMed ID: 1489489
[TBL] [Abstract][Full Text] [Related]
7. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I.
Roubey RA; Pratt CW; Buyon JP; Winfield JB
J Clin Invest; 1992 Sep; 90(3):1100-4. PubMed ID: 1522218
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid syndrome and the relevance of antibodies to negatively charged phospholipids in diagnostic evaluation.
Tebo AE
Lupus; 2014 Oct; 23(12):1313-6. PubMed ID: 25228736
[TBL] [Abstract][Full Text] [Related]
9. Phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies and antiphospholipid syndrome.
Kaburaki J; Kuwana M; Yamamoto M; Kawai S; Matsuura E; Ikeda Y
Intern Med; 1996 Feb; 35(2):105-10. PubMed ID: 8680096
[TBL] [Abstract][Full Text] [Related]
10. Effect of antiphospholipid antibodies on beta(2) glycoprotein I-phospholipid Interaction.
Gharavi AE; Cucurull E; Tang H; Silver RM; Branch DW
Am J Reprod Immunol; 1998 May; 39(5):310-5. PubMed ID: 9602248
[TBL] [Abstract][Full Text] [Related]
11. Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen.
Arvieux J; Roussel B; Jacob MC; Colomb MG
J Immunol Methods; 1991 Oct; 143(2):223-9. PubMed ID: 1940391
[TBL] [Abstract][Full Text] [Related]
12. Phospholipid-independent binding of beta 2glycoprotein I by IgA from patients with antiphospholipid syndrome.
Galazka MW; Keil LB; Kohles J; Petersheim M; DeBari VA
Ann Clin Lab Sci; 1998; 28(3):153-9. PubMed ID: 9646856
[TBL] [Abstract][Full Text] [Related]
13. Serological detection of antiphospholipid antibodies.
Harris EN
Stroke; 1992 Feb; 23(2 Suppl):I3-6. PubMed ID: 1561672
[TBL] [Abstract][Full Text] [Related]
14. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of three monoclonal IgM antiphospholipid antibodies recognizing different phospholipid antigens.
Buschmann C; Fischer C; Ochsenhirt V; Neukirch C; Lackner KJ; von Landenberg P
Ann N Y Acad Sci; 2005 Jun; 1051():240-54. PubMed ID: 16126965
[TBL] [Abstract][Full Text] [Related]
17. Specificities and characteristics of beta 2 glycoprotein I-induced antiphospholipid antibodies.
Gharavi AE; Sammaritano LR; Bovastro JL; Wilson WA
J Lab Clin Med; 1995 Jun; 125(6):775-8. PubMed ID: 7769372
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome.
Cabral AR; Cabiedes J; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1894-8. PubMed ID: 8991988
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies differ in aPL cofactor requirement.
Sammaritano LR; Lockshin MD; Gharavi AE
Lupus; 1992 Feb; 1(2):83-90. PubMed ID: 1301968
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface.
Pengo V; Biasiolo A; Fior MG
Thromb Haemost; 1995 Jan; 73(1):29-34. PubMed ID: 7537919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
